Verrica Pharmaceuticals Statistics
Total Valuation
VRCA has a market cap or net worth of $298.64 million. The enterprise value is $296.14 million.
| Market Cap | 298.64M |
| Enterprise Value | 296.14M |
Important Dates
The next estimated earnings date is Tuesday, August 6, 2024, before market open.
| Earnings Date | Aug 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
VRCA has 42.42 million shares outstanding. The number of shares has increased by 8.04% in one year.
| Shares Outstanding | 42.42M |
| Shares Change (YoY) | +8.04% |
| Shares Change (QoQ) | +0.35% |
| Owned by Insiders (%) | 34.97% |
| Owned by Institutions (%) | 42.55% |
| Float | 15.05M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 33.51 |
| Forward PS | 13.81 |
| PB Ratio | 198.04 |
| P/FCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 33.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.17, with a Debt / Equity ratio of 30.80.
| Current Ratio | 3.17 |
| Quick Ratio | 2.92 |
| Debt / Equity | 30.80 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -11.85 |
Financial Efficiency
Return on equity (ROE) is -271.40% and return on invested capital (ROIC) is -161.14%.
| Return on Equity (ROE) | -271.40% |
| Return on Assets (ROA) | -105.10% |
| Return on Capital (ROIC) | -161.14% |
| Revenue Per Employee | $89,130 |
| Profits Per Employee | -$807,370 |
| Employee Count | 100 |
| Asset Turnover | 0.12 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -0.57% in the last 52 weeks. The beta is 1.56, so VRCA's price volatility has been higher than the market average.
| Beta (5Y) | 1.56 |
| 52-Week Price Change | -0.57% |
| 50-Day Moving Average | 8.19 |
| 200-Day Moving Average | 5.93 |
| Relative Strength Index (RSI) | 40.52 |
| Average Volume (20 Days) | 251,049 |
Short Selling Information
The latest short interest is 3.91 million, so 9.23% of the outstanding shares have been sold short.
| Short Interest | 3.91M |
| Short Previous Month | 3.57M |
| Short % of Shares Out | 9.23% |
| Short % of Float | 26.00% |
| Short Ratio (days to cover) | 17.62 |
Income Statement
In the last 12 months, VRCA had revenue of $8.91 million and -$80.74 million in losses. Loss per share was -$1.76.
| Revenue | 8.91M |
| Gross Profit | 7.10M |
| Operating Income | -77.27M |
| Pretax Income | -80.74M |
| Net Income | -80.74M |
| EBITDA | -73.48M |
| EBIT | -74.46M |
| Loss Per Share | -$1.76 |
Balance Sheet
The company has $48.94 million in cash and $46.44 million in debt, giving a net cash position of $2.50 million or $0.06 per share.
| Cash & Cash Equivalents | 48.94M |
| Total Debt | 46.44M |
| Net Cash | 2.50M |
| Net Cash Per Share | $0.06 |
| Equity (Book Value) | 1.51M |
| Book Value Per Share | 0.04 |
| Working Capital | 42.01M |
Cash Flow
In the last 12 months, operating cash flow was -$53.93 million and capital expenditures -$351,000, giving a free cash flow of -$54.29 million.
| Operating Cash Flow | -53.93M |
| Capital Expenditures | -351,000 |
| Free Cash Flow | -54.29M |
| FCF Per Share | -$1.17 |
Margins
Gross margin is 79.63%, with operating and profit margins of -866.91% and -905.83%.
| Gross Margin | 79.63% |
| Operating Margin | -866.91% |
| Pretax Margin | -905.83% |
| Profit Margin | -905.83% |
| EBITDA Margin | -824.44% |
| EBIT Margin | -835.36% |
| FCF Margin | -609.05% |
Dividends & Yields
VRCA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -8.04% |
| Shareholder Yield | -8.04% |
| Earnings Yield | -27.04% |
| FCF Yield | -18.18% |
Analyst Forecast
The average price target for VRCA is $13.50, which is 91.76% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $13.50 |
| Price Target Difference | 91.76% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (5Y) | 132.41% |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
VRCA has an Altman Z-Score of -5.34 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -5.34 |
| Piotroski F-Score | 1 |